Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genocea Biosciences Inc | GNCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -1.33% | 2.22 | 2.31 | 2.19 | 2.27 | 2.25 | 13:03:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.20 | 2.22 | 0.02 | 0.9% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 97 | 28,819 | $ 2.25 | $ 64,941 | 129,141 | 0.28 - 12.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:13:23 | 3 | $ 2.2199 | USD |
Genocea Biosciences Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 57.53M | 26.15M | $ -27.81M | -2.85 | - | 25.70M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 1.70% |
Genocea Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNCA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.32 | 2.56 | 2.19 | 2.42 | 165,718 | -0.10 | -4.31% |
| 1 Month | 2.45 | 2.56 | 1.99 | 2.27 | 153,736 | -0.23 | -9.39% |
| 3 Months | 3.61 | 3.6201 | 1.99 | 2.62 | 119,065 | -1.39 | -38.5% |
| 6 Months | 5.71 | 7.21 | 1.99 | 3.90 | 259,376 | -3.49 | -61.12% |
| 1 Year | 0.6114 | 12.22 | 0.28 | 3.18 | 431,691 | 1.61 | 263.1% |
| 3 Years | 3.80 | 12.22 | 0.28 | 2.30 | 546,644 | -1.58 | -41.58% |
| 5 Years | 8.8977 | 16.18 | 0.28 | 3.57 | 475,378 | -6.68 | -75.05% |
Genocea Biosciences Description
| Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines. |
